Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Traumatic Optic Neuropathy Treatment Trial 2; Efficacy of Different Doses of Erythropoietin. A Multicenter, Double Blind RCT

NCT03308448 is registered in ClinicalTrials.gov with Iran University of Medical Sciences as lead sponsor.

NCT NCT03308448
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03308448 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Traumatic Optic Neuropathy Treatment Trial 2; Efficacy of Different Doses of Erythropoietin. A Multicenter, Double Blind RCT
Lead sponsor
Iran University of Medical Sciences
Phase
Phase 3
Overall status
Completed
Start date
January 6, 2018
Completion date
March 2, 2023
Enrollment
93 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

traumatic optic neuropathy